EHRA Premium Access

Real-world outcomes of antithrombotic treatment in anticoagulant-naive octogenarian patients with non-valvular atrial fibrillation

Congress Presentation

About the speaker

Doctor Minsu Kim

Chungnam National University Sejong Hospital, Sejong (Korea (Republic of))
0 follower

10 more presentations in this session

Single-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic prevention in patients with atrial fibrillation.

Speaker: Associate Professor K. Neven (Essen, DE)


Perception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K antagonist to dabigatran for stroke prophylaxis in atrial fibrillation (RE-SONANCE study)

Speaker: Doctor R. Tieleman (Groningen, NL)


Left atrial appendage occlusion using novel lambre, amulet and watchman in atrial fibrillation

Speaker: Doctor S. Chen (Greifswald, DE)


Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study

Speaker: Professor J. Mansourati (Brest, FR)


Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study

Speaker: Miss D. Mlayeh (Aulnay sous Bois, FR)


Access the full session

Poster session 1 - Atrial Fibrillation - Stroke Prevention

Speakers: Doctor M. Kim, Associate Professor K. Neven, Doctor R. Tieleman, Doctor S. Chen, Professor J. Mansourati...

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb